These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36480397)

  • 41. Craving and acute effects of alcohol in youths' daily lives: Associations with alcohol use disorder severity.
    Treloar H; Miranda R
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):303-313. PubMed ID: 28627928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drinking Status Between Ages 50 and 55 for Men From the San Diego Prospective Study Who Developed DSM-IV Alcohol Abuse or Dependence in Prior Follow-Ups.
    Gonçalves PD; Schuckit MA; Smith TL
    J Stud Alcohol Drugs; 2017 Jul; 78(4):512-520. PubMed ID: 28728633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acceptance and Commitment Therapy in the Treatment of Alcohol Use Disorder and Comorbid Affective Disorder: A Pilot Matched Control Trial.
    Thekiso TB; Murphy P; Milnes J; Lambe K; Curtin A; Farren CK
    Behav Ther; 2015 Nov; 46(6):717-28. PubMed ID: 26520216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained effectiveness and cost-effectiveness of Counselling for Alcohol Problems, a brief psychological treatment for harmful drinking in men, delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial.
    Nadkarni A; Weiss HA; Weobong B; McDaid D; Singla DR; Park AL; Bhat B; Katti B; McCambridge J; Murthy P; King M; Wilson GT; Kirkwood B; Fairburn CG; Velleman R; Patel V
    PLoS Med; 2017 Sep; 14(9):e1002386. PubMed ID: 28898239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Causal Network Modeling of the Determinants of Drinking Behavior in Comorbid Alcohol Use and Anxiety Disorder.
    Anker JJ; Kummerfeld E; Rix A; Burwell SJ; Kushner MG
    Alcohol Clin Exp Res; 2019 Jan; 43(1):91-97. PubMed ID: 30371947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
    Shmulewitz D; Aharonovich E; Witkiewitz K; Anton RF; Kranzler HR; Scodes J; Mann KF; Wall MM; Hasin D;
    Am J Psychiatry; 2021 Jun; 178(6):548-559. PubMed ID: 33472388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of 10 add-on HF-rTMS treatment sessions on alcohol use and craving among detoxified inpatients with alcohol use disorder: a randomized sham-controlled clinical trial.
    Hoven M; Schluter RS; Schellekens AF; van Holst RJ; Goudriaan AE
    Addiction; 2023 Jan; 118(1):71-85. PubMed ID: 35971295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of the Unified Protocol for the treatment of comorbid alcohol use and anxiety disorders: Study protocol and methods.
    Farchione TJ; Fitzgerald HE; Curreri A; Janes AC; Gallagher MW; Sbi S; Eustis EH; Barlow DH
    Contemp Clin Trials; 2021 Sep; 108():106512. PubMed ID: 34284152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
    Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
    JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. End-of-treatment abstinence self-efficacy, behavioral processes of change, and posttreatment drinking outcomes in Project MATCH.
    Crouch TB; DiClemente CC; Pitts SC
    Psychol Addict Behav; 2015 Sep; 29(3):706-15. PubMed ID: 25961145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of pretreatment and posttreatment depressive symptoms on alcohol consumption following treatment in Project MATCH.
    Gamble SA; Conner KR; Talbot NL; Yu Q; Tu XM; Connors GJ
    J Stud Alcohol Drugs; 2010 Jan; 71(1):71-7. PubMed ID: 20105416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders.
    Sannibale C; Teesson M; Creamer M; Sitharthan T; Bryant RA; Sutherland K; Taylor K; Bostock-Matusko D; Visser A; Peek-O'Leary M
    Addiction; 2013 Aug; 108(8):1397-1410. PubMed ID: 25328957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Mobile Phone App Featuring Cue Exposure Therapy As Aftercare for Alcohol Use Disorders: An Investigator-Blinded Randomized Controlled Trial.
    Mellentin AI; Nielsen B; Nielsen AS; Yu F; Mejldal A; Nielsen DG; Stenager E
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13793. PubMed ID: 31420960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial].
    Schadé A; Marquenie LA; van Balkom AJ; Koeter MM; van den Brink W; van Dyck R
    Tijdschr Psychiatr; 2008; 50(3):137-48. PubMed ID: 18324601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trajectories of change in subclinical anxiety and alcohol use during alcohol treatment: A parallel process growth model.
    Hurlocker MC; Carlon H; Pearson MR; Hijaz D
    Drug Alcohol Depend; 2023 May; 246():109838. PubMed ID: 36989706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment for alcohol dependence in Catalonia: health outcomes and stability of drinking patterns over 20 years in 850 patients.
    Gual A; Bravo F; Lligoña A; Colom J
    Alcohol Alcohol; 2009; 44(4):409-15. PubMed ID: 19491281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.
    Kushner MG; Abrams K; Thuras P; Hanson KL; Brekke M; Sletten S
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1432-43. PubMed ID: 16131851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology.
    Gowin J; Sloan ME; Swan JE; Momenan R; Ramchandani VA
    Psychopharmacology (Berl); 2019 Feb; 236(2):775-785. PubMed ID: 30456539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of behavior change during alcohol treatment among negative affect drinkers: A time-varying effect model analysis using 84 consecutive days of ecological momentary assessment.
    Zhao J; Linn BK; Stasiewicz PR; Wilding GE; LaBarre C; Bradizza CM
    Psychol Addict Behav; 2024 Feb; 38(1):36-46. PubMed ID: 37199961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.